Ratios Revealed: Decoding Madrigal Pharmaceuticals Inc (MDGL)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was $337.61 for the day, up 1.90% from the previous closing price of $331.32. In other words, the price has increased by $1.90 from its previous closing price. On the day, 0.77 million shares were traded. MDGL stock price reached its highest trading level at $337.63 during the session, while it also had its lowest trading level at $316.665.

Ratios:

Our analysis of MDGL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.93 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.

On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $382.

On April 22, 2024, BofA Securities started tracking the stock assigning a Underperform rating and target price of $150.BofA Securities initiated its Underperform rating on April 22, 2024, with a $150 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 01 ’24 when Levy Richard S sold 5,000 shares for $300.94 per share. The transaction valued at 1,504,703 led to the insider holds 11,012 shares of the business.

RICHARD S LEVY bought 5,000 shares of MDGL for $1,296,700 on Nov 01 ’24. On Sep 09 ’24, another insider, Sibold William John, who serves as the President and CEO of the company, sold 6,363 shares for $243.83 each. As a result, the insider received 1,551,490 and left with 55,887 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDGL now has a Market Capitalization of 7363408896 and an Enterprise Value of 6483925504. For the stock, the TTM Price-to-Sale (P/S) ratio is 95.87 while its Price-to-Book (P/B) ratio in mrq is 9.47. Its current Enterprise Value per Revenue stands at 84.412 whereas that against EBITDA is -11.85.

Stock Price History:

Over the past 52 weeks, MDGL has reached a high of $337.44, while it has fallen to a 52-week low of $133.99. The 50-Day Moving Average of the stock is 46.33%, while the 200-Day Moving Average is calculated to be 39.46%.

Shares Statistics:

MDGL traded an average of 348.83K shares per day over the past three months and 768030 shares per day over the past ten days. A total of 19.88M shares are outstanding, with a floating share count of 18.15M. Insiders hold about 16.76% of the company’s shares, while institutions hold 102.09% stake in the company. Shares short for MDGL as of 1728950400 were 4051836 with a Short Ratio of 11.62, compared to 1726185600 on 3728767. Therefore, it implies a Short% of Shares Outstanding of 4051836 and a Short% of Float of 26.669999999999998.

Most Popular